Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V36715 | (Pro3)-Dynorphin A (1-11) amide | 289636-76-6 | (Pro3)-Dynorphin A (1-11) amide is a peptide compound. |
|
V36881 | (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) | 161650-01-7 | (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) is a peptide compound. |
|
V36865 | (Pro34)-Neuropeptide Y (porcine) | 128768-54-7 | (Pro34)-Neuropeptide Y (porcine) is a peptide compound. |
|
V37080 | (Pyr16)-VIP (16-28) (chicken) | 73073-47-9 | (Pyr16)-VIP (16-28) (chicken) is a peptide compound. |
|
V37081 | (Pyr16)-VIP (16-28) (human, bovine, porcine, rat) | 134907-86-1 | (Pyr16)-VIP (16-28) (human, bovine, porcine, rat) is a peptide compound. |
|
|
V37065 | (Pyr4,Cys(H-Cys-OH)6,Arg8)-Vasopressin (4-8) | 87553-80-3 | (Pyr4,Cys(H-Cys-OH)6,Arg8)-Vasopressin (4-8) is a peptide compound. |
|
V37032 | (Pyr5)-Substance P (5-11) | 56104-22-4 | [Glp5] Substance P (5-11) is an octapeptide. |
|
V37033 | (Pyr5,N-Me-Phe8,Sar9)-Substance P (5-11) | 77128-69-9 | [Glp5,(Me)Phe8,Sar9] Substance P (5-11) (DiMe-C7) is a Substance P analog of neurokinin 1 receptor (NK1R) in rat brain The effect is roughly the same as that of Substance P, but the action time is greatly extended. |
|
V37034 | (Pyr6)-Substance P (6-11) | 61123-13-5 | [Glp6] Substance P (6-11) is the analog of substance P (6-11). |
|
V34904 | (Sar1)-Angiotensin I/II (1-7) amide | 126112-22-9 | (Sar1)-Angiotensin I/II (1-7) amide is a peptide compound. |
|
V34896 | (Sar1)-Angiotensin II | 51833-69-3 | (Sar1)-Angiotensin II, an analog of angiotensin II, is a specific agonist of the angiotensin AT1 receptor. |
|
V34897 | (Sar1,Ala8)-Angiotensin II | 38027-95-1 | (Sar1,Ala8)-Angiotensin II is a peptide compound. |
|
V34898 | (Sar1,Gly8)-Angiotensin II | 51887-62-8 | (Sar1,Gly8)-Angiotensin II is a peptide compound. |
|
V34899 | (Sar1,Ile4·8)-Angiotensin II | 185461-45-4 | (Sar1,Ile4,8)-Angiotensin II is a functionally selective angiotensin II type 1 receptor (AT1R) agonist. |
|
V34900 | (Sar1,Thr8)-Angiotensin II | 53632-49-8 | (Sar1,Thr8)-Angiotensin II is a peptide compound. |
|
V34901 | (Sar1,Tyr(Me)4)-Angiotensin II | 88874-29-7 | (Sar1,Tyr(Me)4)-Angiotensin II is a peptide compound. |
|
V34902 | (Sar1,Val5,Ala8)-Angiotensin II | 34273-10-4 | Saralasin [(Sar1,Val5,Ala8)-Angiotensin II], a peptide compound,is a partial agonist/competitive non-selective antagonist of angiotensin II receptors, though it is commonly mistaken as a competitive antagonist. |
|
|
V36698 | (Ser(Ac)7)-Dermorphin | (Ser(Ac)7)-Dermorphin is a peptide compound. | |
|
V36939 | (Ser25)-Protein Kinase C (19-31) | 136795-05-6 | [Ser25] Protein Kinase C (19-31) is a protein kinase C (PKC) substrate (Km: 0.3 μM). |
|
V36899 | (Ser4,Ile8)-Oxytocin | 550-21-0 | Isotocin ((Ser4,Ile8)-Oxytocin) is a bioactive peptide discovered by peptide screening. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
